Lanted CCl4-treated liver four weeks just after transplantation by Masson Trichrome staining. SHED-HepT showed the
Lanted CCl4-treated liver four weeks just after transplantation by Masson Trichrome staining. SHED-HepT showed the decreased levels of alpha-smooth muscle actin 2, smooth muscle, aorta (ACTA2)-positive cells and fibrogenesisrelated marker genes for Acta2, matrix metalloprotease two, transforming development factor beta, and TNFA inside the recipient liver by immunohistochemical evaluation and RTqPCR (Further file 1: Supplementary Figs. 5f, 5 g).Transplanted donor SHED-Heps integrate in liver tissue of chronically CCl4-treated miceIn vivo cell tracking analysis showed that fluorescent intensity was PI3KC3 Purity & Documentation detected around the recipient body corresponding to the liver 24 h following DiR-labeled SHED-HepT, but not on handle mouse body (Fig. 1b). FCM analysis showed the expression of a ubiquitous human cell marker, human leukocyte antigens A, B, and C (HLAABC) on WLCs isolated from the recipient mice 4 weeks right after transplantation (Fig. 1c). Immunohistochemical analysis working with human-specific antibodies showed that HLA-ABC-, human hepatocyte-specific hepatocyte paraffin 1- (HepPar1-), and human ALB-positive cells had been detected inside the liver parenchymal periphery of recipient mice (Fig. 1d ). No signal was detected on human and mouse liver tissues by immunohistochemical manage tests employing isotype-matched antibodies rather with the human-specific antibodies (Further file 1: Supplementary Fig. 6). Antibody cross-reactivity test evaluated the human specificity of HLA-ABC, HepPar1, and human ALB antibodies, but not the mouse specificity on humanYuniartha et al. Stem Cell Analysis Therapy(2021) 12:Web page 5 ofFig. 1 (See legend on next page.)Yuniartha et al. Stem Cell Investigation Therapy(2021) 12:Web page six of(See figure on previous page.) Fig. 1 Transplanted donor SHED-Heps engraft without cell fusion in livers of recipient CCl4-treated mice. a A schema of SHED-Hep transplantation (SHED-HepT) into chronically CCl4-treated mice. Mice had been intraperitoneally treated with CCl4 (1 mg/kg in olive oil, red Bombesin Receptor drug arrowheads) twice a week for 8 weeks and administrated SHED-Heps (1.0 106/mouse) four weeks soon after CCl4 therapy. The mice had been harvested eight weeks soon after CCl4 treatment. b Representative pictures of in vivo kinetics of donor SHED-Heps have been detected in CCl4-treated mice 24 h after SHED-HepT by DiR labeling. c Distribution of donor SHED-Heps was analyzed in the livers 4 weeks following the transplantation. Representative histogram of human leucocyte antigens A, B, and C (HLA-ABC) expression within the recipient complete liver cells (WLCs) by flow cytometric (FCM) assay. Area filled with red: target antibody-stained histograms; solid line: isotype-matched control-stained histograms. Number indicates averages from the constructive rate (c). Representative pictures of HLA-ABC (d), hepatocyte paraffin 1 antigen (HepPar1; e), and human albumin (hALB; f) have been detected by immunohistochemical analysis. Serum levels of hALB by enzyme-linked immunosorbent assay (ELISA). n = 5. nd, no detection. The graph bars represent the suggests normal error of imply (SEM) (g). Representative photos with the expression of HepPar1 and hALB (h) and HepPar1 and mouse albumin (mALB, i) have been detected by double immunofluorescent evaluation. Nuclei had been stained with four,6-diamidino-2-phenylindole (DAPI). Merge: merged image. b, d : Cont, olive oil-treated mice; CCl4, CCl4-treated mice; SHED-Hep, SHED-Hep-transplanted CCl4-treated mice. d , h, i: Scale bars, 50 m (d ) and 10 m (h, i)and mouse liver tissues (Extra file 1: Supplementary Figs. 7ac). Hom.